254 related articles for article (PubMed ID: 28872689)
1. Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies.
Cao L; Kwara A; Greenblatt DJ
J Pharm Pharmacol; 2017 Dec; 69(12):1762-1772. PubMed ID: 28872689
[TBL] [Abstract][Full Text] [Related]
2. Systemic exposure of Paracetamol (acetaminophen) was enhanced by quercetin and chrysin co-administration in Wistar rats and in vitro model: risk of liver toxicity.
Pingili RB; Pawar AK; Challa SR
Drug Dev Ind Pharm; 2015; 41(11):1793-800. PubMed ID: 25678313
[TBL] [Abstract][Full Text] [Related]
3. Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation.
Jiang Y; Fan X; Wang Y; Tan H; Chen P; Zeng H; Huang M; Bi H
Chem Biol Interact; 2015 Apr; 231():83-9. PubMed ID: 25753323
[TBL] [Abstract][Full Text] [Related]
4. 3,5,5-trimethyl-hexanoyl-ferrocene diet protects mice from moderate transient acetaminophen-induced hepatotoxicity.
Moon MS; Kang BH; Krzeminski J; Amin S; Aliaga C; Zhu J; McDevitt EI; Kocher S; Richie JP; Isom HC
Toxicol Sci; 2011 Dec; 124(2):348-58. PubMed ID: 21908766
[TBL] [Abstract][Full Text] [Related]
5. Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and Cyp2e1(-/-) mice.
Wolf KK; Wood SG; Allard JL; Hunt JA; Gorman N; Walton-Strong BW; Szakacs JG; Duan SX; Hao Q; Court MH; von Moltke LL; Greenblatt DJ; Kostrubsky V; Jeffery EH; Wrighton SA; Gonzalez FJ; Sinclair PR; Sinclair JF
Drug Metab Dispos; 2007 Jul; 35(7):1223-31. PubMed ID: 17392391
[TBL] [Abstract][Full Text] [Related]
6. Effects of flavonoids on cytochrome P450-dependent acetaminophen metabolism in rats and human liver microsomes.
Li Y; Wang E; Patten CJ; Chen L; Yang CS
Drug Metab Dispos; 1994; 22(4):566-71. PubMed ID: 7956731
[TBL] [Abstract][Full Text] [Related]
7. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.
Zaher H; Buters JT; Ward JM; Bruno MK; Lucas AM; Stern ST; Cohen SD; Gonzalez FJ
Toxicol Appl Pharmacol; 1998 Sep; 152(1):193-9. PubMed ID: 9772215
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of hyperoside against acetaminophen (APAP) induced liver injury through enhancement of APAP clearance.
Xie W; Jiang Z; Wang J; Zhang X; Melzig MF
Chem Biol Interact; 2016 Feb; 246():11-9. PubMed ID: 26772156
[TBL] [Abstract][Full Text] [Related]
9. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury.
Shayiq RM; Roberts DW; Rothstein K; Snawder JE; Benson W; Ma X; Black M
Hepatology; 1999 Feb; 29(2):451-63. PubMed ID: 9918922
[TBL] [Abstract][Full Text] [Related]
10. Role of CYP1A2 in the hepatotoxicity of acetaminophen: investigations using Cyp1a2 null mice.
Tonge RP; Kelly EJ; Bruschi SA; Kalhorn T; Eaton DL; Nebert DW; Nelson SD
Toxicol Appl Pharmacol; 1998 Nov; 153(1):102-8. PubMed ID: 9875304
[TBL] [Abstract][Full Text] [Related]
11. Hepatoprotective effect of isoquercitrin against acetaminophen-induced liver injury.
Xie W; Wang M; Chen C; Zhang X; Melzig MF
Life Sci; 2016 May; 152():180-9. PubMed ID: 27049115
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation of acetaminophen hepatotoxicity by the anthelmentic drug fenbendazole.
Gardner CR; Mishin V; Laskin JD; Laskin DL
Toxicol Sci; 2012 Feb; 125(2):607-12. PubMed ID: 22048645
[TBL] [Abstract][Full Text] [Related]
13. Geranylgeranylacetone protects against acetaminophen-induced hepatotoxicity by inducing heat shock protein 70.
Nishida T; Matsura T; Nakada J; Togawa A; Kai M; Sumioka I; Minami Y; Inagaki Y; Ishibe Y; Ito H; Ohta Y; Yamada K
Toxicology; 2006 Feb; 219(1-3):187-96. PubMed ID: 16377054
[TBL] [Abstract][Full Text] [Related]
14. Eriodictyol, Not Its Glucuronide Metabolites, Attenuates Acetaminophen-Induced Hepatotoxicity.
Wang Z; Lan Y; Chen M; Wen C; Hu Y; Liu Z; Ye L
Mol Pharm; 2017 Sep; 14(9):2937-2951. PubMed ID: 28654297
[TBL] [Abstract][Full Text] [Related]
15. Protection afforded by pre- or post-treatment with 4-phenylbutyrate against liver injury induced by acetaminophen overdose in mice.
Shimizu D; Ishitsuka Y; Miyata K; Tomishima Y; Kondo Y; Irikura M; Iwawaki T; Oike Y; Irie T
Pharmacol Res; 2014 Sep; 87():26-41. PubMed ID: 24951965
[TBL] [Abstract][Full Text] [Related]
16. Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases.
Boersma MG; van der Woude H; Bogaards J; Boeren S; Vervoort J; Cnubben NH; van Iersel ML; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2002 May; 15(5):662-70. PubMed ID: 12018987
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition of human liver cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes by rose bengal: system-dependent effects on inhibitory potential.
Kazmi F; Haupt LJ; Horkman JR; Smith BD; Buckley DB; Wachter EA; Singer JM
Xenobiotica; 2014 Jul; 44(7):606-14. PubMed ID: 24405273
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of diallyl sulfone against acetaminophen-induced hepatotoxicity in mice.
Lin MC; Wang EJ; Patten C; Lee MJ; Xiao F; Reuhl KR; Yang CS
J Biochem Toxicol; 1996; 11(1):11-20. PubMed ID: 8806047
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory Effects of Selected Antituberculosis Drugs on Common Human Hepatic Cytochrome P450 and UDP-glucuronosyltransferase Enzymes.
Cao L; Greenblatt DJ; Kwara A
Drug Metab Dispos; 2017 Sep; 45(9):1035-1043. PubMed ID: 28663285
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of human cytochrome P450 by cudratricusxanthone A.
Sim J; Choi E; Lee YM; Jeong GS; Lee S
Food Chem Toxicol; 2015 Jul; 81():171-175. PubMed ID: 25936586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
